This message was sent to ##Email##. To advertise in this publication please click here

Sept. 23, 2020

FSP NEWS

FSP Accepting Nominations for Leadership Positions The Florida Society of Pathologists Nominating Committee is accepting nominations from FSP members in good standing for the FSP Board, Committees, and for the Florida delegation to the Florida Medical Association (FMA). The FSP is one of the most active, engaged, talented, dedicated, and exciting state pathology societies in the country! Being an active leader in the FSP will enrich both your professional and personal life and will benefit your chosen profession. Make an impact as a leader and become a part of the future of YOUR state society! Complete the survey on the FSP website here to indicate your interest. READ MORE

Register Now for Complimentary CME Webinar — September 29 The FSP is hosting a free webinar led by expert pathologist Michael Feely, DO on Tuesday, September 29, 2020 at 7 pm ET. This live scope session webinar will systematically cover, from gut to butt, both atypical presentations of common infections as well as infrequently encountered, but clinically relevant, infectious disease of the gastrointestinal tract as they present in surgical pathology. This activity will offer 1.0 AMA PRA Category 1 Credits™. Pre-registration is required, and registration is being accepted online here. READ MORE

CAP Announces Board of Governors Elections Results The results of the 2020 CAP Board of Governors Elections are now final. Elected governors include Kalisha A. Hill, MD, MBA, FCAP, Bradley S. Karon, MD, PhD, FCAP, Jonathan Louis Myles, MD, FCAP, and A. Joe Saad, MD, FCAP. Congratulations to those elected! To learn more about the elected governors visit the CAP website. READ MORE

SPONSOR SPOTLIGHT

INDUSTRY NEWS

Research pathology fellowship in precision medicine Nature The Englander Institute for Precision Medicine and the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine offer a two-year Research Pathology Fellowship in Precision Medicine. With a major exposure to oncologic pathology and a comprehensive translational research component, this training program will focus on the application of next-generation sequencing platforms to identify and validate novel alterations in an array of tumor types. READ MORE

A 58-year-old man with advanced renal cell carcinoma Targeted Oncology Robert Alter, MD, of John Theurer Cancer Center, describes the rationale for treating a 58-year-old male with advanced renal cell carcinoma with the combination of lenvatinib and everolimus following progression on first-line therapy. READ MORE

Optimize Your Pathology Billing Our Anatomical and Clinical Pathology Billing expertise maximizes collections for practices nationwide. Click here to find out if YOUR billing is optimized! MORE INFO

AI tech challenge looks to bring pathology innovations to healthcare European Pharmaceutical Manufacturer Whitespace, in partnership with IBM, is seeking a new generation of AI solutions from across EMEA to help Pfizer Healthcare Hub:London address the challenge of bringing histopathology innovations to healthcare services and accelerate digital pathology development. Currently, much of the analysis and reporting in pathology laboratories is being performed manually. This can be an expensive, labour-intensive and time-consuming process for healthcare organisations. The development of an AI/Machine Learning (ML) Vision solution could be a potential approach in addressing such issues. READ MORE

Assessing biomarkers in metastatic breast cancer Medscape Growing evidence demonstrates that changes in biomarker status occur frequently during the metastatic progression of breast cancer and can affect treatment response. "When a woman is first diagnosed with metastatic disease, it is important to reevaluate markers, because these do occasionally change from the time of primary diagnosis." says Eric Winer, MD, a medical oncologist at Dana-Farber Cancer Institute. READ MORE

COVID-19 vaccine research builds on US successes U.S. Embassy in Georgia U.S. leadership in vaccine development and infectious disease treatment is vital to ongoing efforts to combat COVID-19 worldwide. U.S. research is responsible for vaccines that protect the world’s citizens from deadly infectious diseases like yellow fever, measles and polio. In addition, the U.S. continues to invest billions worldwide to combat HIV/AIDS. READ MORE

Double digit decline in infectious disease research during coronavirus pandemic ContagionLive As resources have been poured into the COVID-19 response, other infectious disease priorities have been displaced. Patrick Howie, CEO of a firm which aggregates useful clinical data/analysis, explains. READ MORE

Engineered bacteria churn out cancer biomarkers Cornell Chronicle These complex sugar molecules are attached to 80% of the proteins in the human body, making them an essential ingredient of life. But this process, known as glycosylation, has been somewhat overshadowed by flashier biomolecular processes such as transcription and translation. READ MORE

Innovation changes the way MSK's pathology team cares for patients during COVID-19 pandemic Memorial Sloan Kettering Cancer Center During the COVID-19 pandemic, Memorial Sloan Kettering doctors and nurses have been able to continue to provide high-quality care for people with cancer. They’ve done this through traditional appointments and by offering telemedicine services while working from home. READ MORE

New biomarker can reliably predict aggressiveness of biliary tract cancer News-Medical.Net The cancer called biliary tract cancer (BTC) is not the most widespread form of cancer. In western countries, about 1.6 in 100.000 gets the diagnose every year. It is, however, a very aggressive form of cancer. The majority of patients with BTC are diagnosed with advanced disease and has an average survival of only one year from initiation of chemotherapy. With such narrow survival windows, it is crucial to improve our understanding of the disease. READ MORE

Worried about getting a blood test or pathology sample during coronavirus? Here's what you need to know ABC.net Since March this year, lockdowns, job losses and general upheaval have caused enough stress in our lives. So, getting a routine blood test during the coronavirus pandemic might just tip you over the edge. Many people are worried about whether they might come in contact with COVID-19 at a pathology testing centre. READ MORE

Pathology Today   Connect with FSP Dennis Hall, Director of Publishing, 469-420-2656 | Download media kit Ashley Harrington, Sr. Content Editor, 469-420-2642 | Contribute news Florida Society of Pathologists 6816 Southpoint Parkway, Suite 1000 | Jacksonville, FL 32216 | 904-309-6204 | Contact Us Click here to unsubscribe. Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES 7701 Las Colinas Ridge, Ste. 800, Irving, TX, 75063